Streptomycin plus thiacetazone (thioacetazone) compared with streptomycin plus PAS and with isoniazid plus thiacetazone in the treatment of pulmonary tuberculosis in Rhodesia.
D000293:Adolescent; D000328:Adult; D000636:Aminosalicylic Acids / Q000008:administration & dosage*; D000995:Antitubercular Agents / Q000009:adverse effects / Q000627:therapeutic use; D004096:Dihydrostreptomycin Sulfate / Q000008:administration & dosage; D004352:Drug Resistance, Microbial; D004357:Drug Synergism; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage*; D007565:Jaundice / Q000139:chemically induced; D011859:Radiography; D012877:Skin Manifestations; D013183:Sputum / Q000032:analysis; D013272:Stomach Diseases / Q000139:chemically induced; D013307:Streptomycin / Q000008:administration & dosage*; D013828:Thioacetazone / Q000008:administration & dosage*; D014397:Tuberculosis, Pulmonary / Q000000981:diagnostic imaging / Q000188:drug therapy*; D015030:Zimbabwe
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D013828:Thioacetazone; D004096:Dihydrostreptomycin Sulfate; D007538:Isoniazid; D013307:Streptomycin